ATP-Citrate-Lyase Inhibitor

ATP-Citrate-Lyase Inhibitor is a type of drug that works to inhibit the enzyme ATP-Citrate-Lyase (ACL). This enzyme is responsible for the conversion of citrate to acetyl-CoA, which is then used in the production of fatty acids and cholesterol. By inhibiting this enzyme, the drug can help to reduce the levels of fatty acids and cholesterol in the body, which in turn can help to reduce the risk of developing cardiovascular disease and other related conditions. The drug can also be used to treat certain metabolic disorders, such as type 2 diabetes. In addition, the drug may have anti-inflammatory and anti-cancer properties, which can help to reduce inflammation and the risk of developing cancer.